Neurosoft Bioelectronics develops flexible, stretchable brain-machine interfaces that have already been tested in 10 patients. It has raised USD 7.5 million in seed funding led by Skybound Venture Capital, with the aim of a first commercial launch in the United States.
- Announced on
- Round
- Seed
- Amount
- USD 7.5 M
- Location
- Geneva
- Sector
- Health & medtech, Deep tech
Investors
- Skybound Venture Capital lead
- Protocol Labs
- IAG Capital Partners
- Connecticut Innovations
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic